Olanzapine (Zyprexa)
Revision as of 01:54, 11 June 2023 by Warner-admin (talk | contribs) (Text replacement - ": new" to ": New")
Mechanism of action
Atypical antipsychotic with antiemetic properties, likely through its effect on dopamine receptors. No known antineoplastic properties.
History of changes in PMDA indication
- 2017-12-25: New additional indication and a new dosage indicated for the treatment of gastrointestinal symptoms (nausea and vomiting) associated with the administration of antineoplastic drugs (cisplatin, etc.).
Also known as
- Brand name: Zyprexa